(MENAFN- EIN Presswire)
Anti-Asthmatics And COPD Drugs Global Market Report 2022: Market Size, Trends And Forecast To 2026
The Business Research Company's Anti-Asthmatics And COPD Drugs Global Market Report 2022: Market Size, Trends And Forecast To 2026
LONDON, GREATER LONDON, UK, September 22, 2022 /EINPresswire.com / -- As per The Business Research Company's 'Anti-Asthmatics And COPD Drugs Global Market Report 2022”, the anti-asthmatics and COPD drugs market is expected to grow from $80.73 billion in 2021 to $88.18 billion in 2022 at a compound annual growth rate (CAGR) of 9.2%. The change in the anti-asthmatics and COPD drugs market growth trend is mainly due to the companies stabilizing their output after catering to the demand that grew exponentially during the COVID-19 pandemic in 2020. As per TBRC's anti-asthmatics and COPD drugs market outlook the market is expected to reach $118.78 billion in 2026 at a CAGR of 7.7%. Modifiable risk factors including smoking, lack of physical exercise, and unhealthy eating habits drive the Asthma and COPD drugs market.
Request a Sample now to gain a better understanding of anti-asthmatics and COPD drugs market:
Key Trends In The Anti-Asthmatics And COPD Drugs Market
The use of combination drugs for the treatment of asthma and COPD is increasing. This is due to the greater impact on patient reported outcomes (PROs) compared to monotherapies.
Overview Of The Anti-Asthmatics And COPD Drugs Market
The anti-asthmatics and chronic obstructive pulmonary disease (COPD) market consists of sales of anti-asthmatics and chronic obstructive pulmonary disease (COPD) drugs which are used to relieve the frequency of acute attacks of asthma, emphysema, chronic bronchitis, and nocturnal awakenings.
Learn more on the global anti-asthmatics and COPD drugs market report at:
Anti-Asthmatics And COPD Drugs Global Market Report 2022 from TBRC covers the following information:
Market Size Data
•Forecast period: Historical and Future
•By region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
•By countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
•By Type: Anti-Histamine Drugs, Long-Acting ß2-Agonists (LABA), Inhaled Corticosteriods, Short-Acting Muscarinic Receptor Antagonists (SAMAs), Others (including Combinations)
•By Drug Class: Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs
•By End-User: Asthma Patients, COPD Patients
•By Distribution Channel: Hospital Pharmacies, Private Clinics, Drug Stores, Retail Pharmacies, E-Commerce
•By Geography: The global anti-asthmatics and COPD drugs market is segmented into North America, South America, Asia-Pacific, Eastern Europe, Western Europe, Middle East and Africa. Among these regions, North America holds the largest share in the market.
Major market players such as Novartis AG, Merck & Co, GlaxoSmithKline, Boehringer Ingelheim Gmbh, AstraZeneca, Roche, Teva Pharmaceutical, Vectura, Pfizer and Abbott.
Trends, opportunities, strategies and so much more.
Anti-Asthmatics And COPD Drugs Global Market Report 2022 is one of The Business Research Company's comprehensive reports that provides an overview of anti-asthmatics and COPD drugs market. The market report analyzes anti-asthmatics and COPD drugs global market size, anti-asthmatics and COPD drugs global market growth drivers, anti-asthmatics and COPD drugs global market segments, anti-asthmatics and COPD drugs global market major players, anti-asthmatics and COPD drugs market growth across geographies, anti-asthmatics and COPD drugs market trends and anti-asthmatics and COPD drugs market competitors' revenues and market positioning. The anti-asthmatics and COPD drugs market report enables you to gain insights on opportunities and strategies, as well as identify countries and segments with the highest growth potential.
Not what you were looking for? Go through similar reports by The Business Research Company:
Respiratory Diseases Drugs Global Market Report 2022
Interleukin Inhibitors Global Market Report 2022
Vaporizers, E-Cigarettes, And Other Electronic Nicotine Delivery Systems (ENDS) Global Market Report 2022
About The Business Research Company?
The Business Research Company has published over 3000 industry reports, covering over 3000 market segments and 60 geographies. The reports draw on 150,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders. The reports are updated with a detailed analysis of the impact of COVID-19 on various markets.
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Check out our:
The Business Research Company
+44 20 7193 0708
Visit us on social media:
Legal Disclaimer: MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.